Intervention Review

You have full text access to this OnlineOpen article

Anti-TNF-α treatment for pelvic pain associated with endometriosis

  1. DongHao Lu1,
  2. Huan Song1,
  3. Gang Shi2,*

Editorial Group: Cochrane Menstrual Disorders and Subfertility Group

Published Online: 28 MAR 2013

Assessed as up-to-date: 3 SEP 2012

DOI: 10.1002/14651858.CD008088.pub3

How to Cite

Lu D, Song H, Shi G. Anti-TNF-α treatment for pelvic pain associated with endometriosis. Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No.: CD008088. DOI: 10.1002/14651858.CD008088.pub3.

Author Information

  1. 1

    Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden

  2. 2

    West China Second University Hospital, Sichuan University, Department of Obstetrics and Gynecology, Chengdu, Sichuan, China

*Gang Shi, Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, No. 20, 3rd Section of Ren Min Nan Road, Chengdu, Sichuan, 610041, China. dr.gangshi@gmail.com. gang-shi@163.com.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 28 MAR 2013

SEARCH

[Figure 1]
Figure 1. Study flow diagram.
[Figure 2]
Figure 2. Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.
[Figure 3]
Figure 3. Methodological quality summary: review authors' judgements about each methodological quality item for each included study.
[Figure 4]
Figure 4. Forest plot of comparison: 1 Infliximab versus placebo, outcome: 1.1 Relief of pelvic pain.
[Figure 5]
Figure 5. Forest plot of comparison: 1 Infliximab versus placebo, outcome: 1.2 Adverse events.
[Analysis 1.1]
Analysis 1.1. Comparison 1 Infliximab versus placebo, Outcome 1 Relief of pelvic pain.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Infliximab versus placebo, Outcome 2 Adverse events.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Infliximab versus placebo, Outcome 3 Improvement in endometriotic lesions.
[Analysis 1.4]
Analysis 1.4. Comparison 1 Infliximab versus placebo, Outcome 4 Improvement of endometriosis-related symptoms - dysmenorrhoea.
[Analysis 1.5]
Analysis 1.5. Comparison 1 Infliximab versus placebo, Outcome 5 Improvement of endometriosis-related symptoms - dyspareunia.
[Analysis 1.6]
Analysis 1.6. Comparison 1 Infliximab versus placebo, Outcome 6 Improvement of endometriosis-related symptoms - pelvic tenderness.